Home » Topics » BioWorld Science

BioWorld Science
RSS

Grant supports clinical development of ISA-104 for chronic hepatitis B

July 20, 2021

Lenacapavir confers viral suppression by week 16 in HIV-infected patients

July 20, 2021

Acumen initiates phase I study of ACU-193 in mild cognitive impairment or mild Alzheimer's

July 20, 2021

Modulation of STAT pathway with HODHBt improves NK cell cytotoxicity

July 20, 2021

GS-9822 retargets integration sites and induces deep latent state in vitro

July 20, 2021

CXCL9 levels predict future cardiac aging and vascular dysfunction

July 20, 2021

VX-548 enters phase II development for the treatment of acute pain

July 20, 2021

Loss-of-function variant in SUV39H2 identified in autism spectrum disorder

July 20, 2021

Prometheus initiates phase II ARTEMIS-UC study of PRA-023

July 20, 2021

DSMB recommends continued treatment in phase II portion of OVATION 2 study with GEN-1

July 20, 2021

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
Japan endorses two iPSC drugs for approval under CEA pathway
BioWorld
Japan is backing conditional approvals of Amchepry (raguneprocel, Sumitomo Pharma Co. Ltd./Racthera Co. Ltd.) and Reheart (Cuorips Inc.), positioning them to...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 24, 2026
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...